CORT has been in the news 321% more than usual
Feb 27, 2026, 9:32 AM
-4.84%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
CORT has been in the news recently: Hagens Berman is encouraging investors of Corcept Therapeutics Inc. to reach out after a sharp decline in share value from $70.20 to $34.80. Both the Schall Law Firm and DJS Law Group are advising shareholders to participate in a class action lawsuit related to misleading statements made by the company regarding product approval during the period from October 31, 2024, to December 30, 2025.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.